iRucaparib-AP6 is a highly efficient and specific PARP1 degrader based on Rucaparib by using the
PROTAC approach. iRucaparib-AP6, a non-trapping PARP1 degrader, blocks both the catalytic activity and scaffolding effects of PARP1.
性状
Solid
体外研究(In Vitro)
iRucaparib-AP6 (0-10 μM; 24 hours) decreases PARP-1 level in a dose dependent manner, exhibits a half-maximal degrading concentration (DC50) of 82?nM (Dmax?=?92%).iRucaparib-AP6 (0-20 μM; 24 hours) induces degradation of PARP1 at low concentrations. has not independently confirmed the accuracy of these methods. They are for reference only.Cell Viability Assay
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
-20°C, stored under nitrogen In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
参考文献
[1]. Wang S, et al. Uncoupling of PARP1 trapping and inhibition using selective PARP1 degradation.Nat Chem Biol. 2019 Dec;15(12):1223-1231.
溶解度数据
In Vitro: DMSO : 50 mg/mL (56.37 mM; Need ultrasonic)配制储备液